GAL4 (DBD) activators are specialized chemicals aimed at boosting the function of the DNA-binding domain (DBD) of the GAL4 transcription factor. Originally identified in yeast, the GAL4 protein is widely used as a research tool in eukaryotic biology. It consists of two major domains: the activation domain and the DNA-binding domain. When activated, the DNA-binding domain of GAL4 specifically binds to upstream activating sequences (UAS) to regulate gene expression. The activators for this domain can range from small organic molecules to larger compounds, each with a unique method of facilitating the protein's role in gene regulation. For instance, some GAL4 (DBD) activators function by enhancing the stability of the protein-DNA complex, while others may increase the affinity of the protein for its specific DNA sequences.
The mechanism of action for GAL4 (DBD) activators can be quite intricate and varies depending on the chemical structure and the biological environment. Some of these activators work by interacting with the amino acid residues that directly participate in DNA binding, thereby increasing the protein's affinity for its target sequences. Others might act indirectly, perhaps by modifying the protein conformation, making it easier for the DNA-binding domain to interact with its targets. Additionally, some activators might function by facilitating the translocation of GAL4 into the nucleus, thus enhancing its ability to interact with DNA.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Acts primarily through the activation of adenylate cyclase, increasing cAMP levels which could indirectly stimulate GAL4 (DBD) transcriptional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Known to inhibit phosphodiesterase, thereby raising cAMP levels which can enhance GAL4 (DBD)-mediated transcription. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Acts as an adenosine receptor antagonist and phosphodiesterase inhibitor, leading to increased cAMP levels which may enhance GAL4 (DBD) activity. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A synthetic glucocorticoid that can stimulate GAL4 (DBD) by binding to glucocorticoid response elements present within the target gene's promoter region. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Acts as a glucocorticoid receptor antagonist and can modulate GAL4 (DBD) activity when fused to glucocorticoid receptor domains. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Known to inhibit dihydrofolate reductase, affecting DNA synthesis and potentially activating GAL4 (DBD) by a not yet clarified mechanism. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Binds to retinoic acid receptors, potentially increasing the transcriptional activity of GAL4 (DBD) when fused to these receptors. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
An antibiotic that can activate tetracycline-inducible GAL4 (DBD) systems through binding to specific regulatory elements. | ||||||
Doxycycline-d6 | 564-25-0 unlabeled | sc-218274 | 1 mg | $16500.00 | ||
Similar to tetracycline, it can activate tetracycline-inducible GAL4 (DBD) systems. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
The active form of Vitamin D3 which can modulate GAL4 (DBD) activity when fused to vitamin D receptor domains. | ||||||